First-in-human trial for EPI-321, a novel epigenetic therapy for FSHD targeting D4Z4 epigenome

Return to Grants

Grant Award Details

Grant Type:
Clinical Trial Stage Projects
Grant Number:
CLIN2-20392
Investigator(s):
Name:
Weston Miller
Institution:
Epicrispr Biotechnologies, Inc.
Type:
PI

Award Value:
$8,000,000
Status:
Pre-Active

Grant Application Details

Application Title:

First-in-human trial for EPI-321, a novel epigenetic therapy for FSHD targeting D4Z4 epigenome